-transparent.png){kind=logo}
Evidence is presented which suggests that lithium modifies the mood and behavioral alterations resulting from IV methylphenidate. Specifically, lithium significantly reduces the level of arousal-activation, euphoria-grandiosity, and the total score of manic-state ratings following a methylphenidate challenge. In addition, lithium appears to be capable of modifying the growth hormone response to methylphenidate.
Related Publications
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
April 1990,
Biological psychiatry,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
January 1984,
Psychopharmacology bulletin,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
January 1980,
Psychopharmacology,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
April 1970,
Archives of general psychiatry,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
February 1992,
Journal of child psychology and psychiatry, and allied disciplines,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
May 2010,
American journal of veterinary research,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
November 1987,
The Journal of nervous and mental disease,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
February 1979,
Pharmacology, biochemistry, and behavior,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
May 1974,
Journal of psychiatric research,
L Y Huey, and
D S Janowsky, and
L L Judd, and
A Abrams, and
D Parker, and
P Clopton
September 2002,
Pharmacology & toxicology,
